Elanco Animal Health Incorporated
ELAN
Κατάταξη σε μετοχές
#1821
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces,... Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
Τιμή μετοχής
$23.51
Τελευταίος συγχρονισμός: 2026-10-19
Κεφαλαιοποίηση
$11.74B
Αλλαγή (1 ημέρα)
-0.15%
Αλλαγή (1 έτος)
8.22%
Χώρα
US
Εμπόριο Elanco Animal Health Incorporated (ELAN)
Κατηγορία
Healthcare
EPS για Elanco Animal Health Incorporated (ELAN)
EPS στις June 2026 TTM: $-0.41
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της Elanco Animal Health Incorporated, το τρέχον EPS της εταιρείας (TTM) είναι $-0.41. Στο τέλος του 2023, η εταιρεία είχε EPS $-2.50, αύξηση σε σχέση με το EPS του 2022 που ήταν $-0.15.
Ιστορικό EPS της Elanco Animal Health Incorporated από 2015 έως 2026
EPS στο τέλος κάθε έτους
| Έτος | EPS | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $-0.41 | -160.29% |
| 2024 | $0.68 | -127.20% |
| 2023 | $-2.50 | 1,566.67% |
| 2022 | $-0.15 | -84.54% |
| 2021 | $-0.97 | -23.62% |
| 2020 | $-1.27 | -805.56% |
| 2019 | $0.18 | -35.71% |
| 2018 | $0.28 | -132.18% |
| 2017 | $-0.87 | 569.23% |
| 2016 | $-0.13 | -77.97% |
| 2015 | $-0.59 | 0.00% |
EPS για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | EPS | Διαφορά EPS | Χώρα |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -235.68% |
IN
|
